Alignment Healthcare (ALHC) president sells shares to cover RSU tax withholding

Rhea-AI Filing Summary

Alignment Healthcare, Inc. President Dawn Christine Maroney reported a mandatory sale of 36,749 shares of common stock. The shares were sold in open-market transactions at a weighted-average price of $17.84 per share to cover tax withholding obligations from vesting restricted stock units, and are described as non-discretionary. Following these transactions, Maroney directly holds 1,058,813 shares of Alignment Healthcare common stock. Individual sales occurred at prices ranging from $17.40 to $18.24 per share.

Insider Trade Summary

Net Seller: 36,749 shares ($655,602)

Net Sell 1 txn

Insider Maroney Dawn Christine

Role President

Sold 36,749 shs ($656K)

Type	Security	Shares	Price	Value
Sale	Common Stock	36,749	$17.84	$656K

Holdings After Transaction: Common Stock — 1,058,813 shares (Direct)

Footnotes (1)

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		36,749(1)	D	$17.84(2)	1,058,813	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for Dawn Christine Maroney?

Dawn Christine Maroney reported selling 36,749 shares of Alignment Healthcare common stock. The sale was tied to tax withholding obligations from vesting restricted stock units and was described as non-discretionary, meaning it was not an elective trade for portfolio or valuation reasons.

At what price were the Alignment Healthcare (ALHC) shares sold in this Form 4 filing?

The reported weighted-average sale price was $17.84 per share. According to the filing, the shares were sold in multiple transactions at prices ranging from $17.40 to $18.24 per share, reflecting normal market execution across a trading range on the transaction date.

Why did Dawn Christine Maroney sell Alignment Healthcare (ALHC) shares in this transaction?

The filing states the sale represents shares required to be sold to cover tax withholding obligations related to vesting restricted stock units. It explicitly notes this transaction does not represent a discretionary trade by the reporting person, indicating a routine tax-driven event.

How many Alignment Healthcare (ALHC) shares does Dawn Christine Maroney hold after the reported sale?

After completing the tax-related sale, Dawn Christine Maroney directly holds 1,058,813 shares of Alignment Healthcare common stock. This post-transaction balance, reported in the Form 4, shows she retains a substantial equity position in the company following the mandatory withholding sale.

Does the Alignment Healthcare (ALHC) Form 4 describe the sale as open-market or private?

The transaction is characterized as an open-market sale of common stock. However, the footnote clarifies the sale was made to satisfy tax withholding obligations tied to restricted stock unit vesting, distinguishing it from a discretionary open-market trade based on valuation views.